Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Open for Enrollment
Why is this study being done?
The clinical research results for the Trinity™ BIOLOX delta™ Ceramic-on-Ceramic Total Hip System will be compared to the control device
Clinical success is based upon Harris Hip Scores to evaluate functional status, adverse events, radiological assessments and no device failure (defined as removal, replacement, or modification of any device component).
Who can I contact for additional information about this study?
Rochester: Char Blanchard 507-284-1175
Jacksonville: Shari Kazmerchak 904-953-8354